$ONXX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ONYX PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ONYX PHARMACEUTICALS INC. Get notifications about new insider transactions in ONYX PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | CAGNONI PABLO J | EVP, Global R&D and ... | Option Exercise | D | 87.83 | 34,030 | 2,988,855 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | CAGNONI PABLO J | EVP, Global R&D and ... | Sell | D | 125.00 | 16,257 | 2,032,125 | 0 | 16.3 K to 0 (-100.00 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WIERENGA WENDALL | Director | Option Exercise | D | 88.86 | 5,000 | 444,300 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WIERENGA WENDALL | Director | Option Exercise | D | 76.79 | 2,000 | 153,580 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WIERENGA WENDALL | Director | Option Exercise | D | 37.68 | 5,000 | 188,400 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WIERENGA WENDALL | Director | Option Exercise | D | 35.18 | 5,000 | 175,900 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WIERENGA WENDALL | Director | Option Exercise | D | 30.28 | 5,000 | 151,400 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WIERENGA WENDALL | Director | Option Exercise | D | 28.55 | 1,452 | 41,455 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WIERENGA WENDALL | Director | Option Exercise | D | 29.70 | 10,000 | 297,000 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WIERENGA WENDALL | Director | Option Exercise | D | 55.06 | 10,000 | 550,600 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WIERENGA WENDALL | Director | Option Exercise | D | 11.86 | 5,000 | 59,300 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WIERENGA WENDALL | Director | Option Exercise | D | 29.39 | 10,000 | 293,900 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WIERENGA WENDALL | Director | Option Exercise | D | 32.93 | 10,000 | 329,300 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WIERENGA WENDALL | Director | Sell | D | 125.00 | 2,100 | 262,500 | 0 | 2.1 K to 0 (-100.00 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WIERENGA WENDALL | Director | Sell | U | 125.00 | 9,080 | 1,135,000 | 2,100 | 11.2 K to 2.1 K (-81.22 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP,GC and Corp. Se ... | Option Exercise | D | 88.86 | 16,700 | 1,483,962 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP,GC and Corp. Se ... | Option Exercise | D | 37.68 | 24,563 | 925,534 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP,GC and Corp. Se ... | Option Exercise | D | 37.68 | 903 | 34,025 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP,GC and Corp. Se ... | Option Exercise | D | 37.68 | 16,510 | 622,097 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP,GC and Corp. Se ... | Option Exercise | D | 37.68 | 2,157 | 81,276 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP,GC and Corp. Se ... | Option Exercise | D | 35.18 | 12,489 | 439,363 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP,GC and Corp. Se ... | Option Exercise | D | 35.18 | 3,553 | 124,995 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP,GC and Corp. Se ... | Option Exercise | D | 30.28 | 3,281 | 99,349 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP,GC and Corp. Se ... | Option Exercise | D | 30.28 | 1,969 | 59,621 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP,GC and Corp. Se ... | Option Exercise | D | 32.07 | 1,214 | 38,933 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP,GC and Corp. Se ... | Option Exercise | D | 32.07 | 12,472 | 399,977 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP,GC and Corp. Se ... | Sell | D | 125.00 | 28,150 | 3,518,750 | 0 | 28.2 K to 0 (-100.00 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP,GC and Corp. Se ... | Sell | U | 125.00 | 6,468 | 808,500 | 28,150 | 34.6 K to 28.2 K (-18.68 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Option Exercise | D | 88.86 | 7,000 | 622,020 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Option Exercise | D | 37.68 | 13,222 | 498,205 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Option Exercise | D | 37.68 | 3,069 | 115,640 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Option Exercise | D | 35.18 | 5,403 | 190,078 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Option Exercise | D | 35.18 | 2,618 | 92,101 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Option Exercise | D | 30.28 | 2,549 | 77,184 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Option Exercise | D | 30.28 | 2,555 | 77,365 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Sell | D | 125.00 | 9,550 | 1,193,750 | 0 | 9.6 K to 0 (-100.00 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Sell | U | 125.00 | 200 | 25,000 | 0 | 200 to 0 (-100.00 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Sell | U | 125.00 | 9,824 | 1,228,000 | 9,550 | 19.4 K to 9.6 K (-50.71 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Option Exercise | D | 88.86 | 22,600 | 2,008,236 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Option Exercise | D | 37.68 | 43,044 | 1,621,898 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Option Exercise | D | 37.68 | 2,856 | 107,614 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Option Exercise | D | 35.18 | 38,981 | 1,371,352 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Option Exercise | D | 35.18 | 3,019 | 106,208 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Option Exercise | D | 30.28 | 41,596 | 1,259,527 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Option Exercise | D | 30.28 | 3,904 | 118,213 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Option Exercise | D | 34.48 | 41,450 | 1,429,196 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Sell | D | 125.00 | 31,150 | 3,893,750 | 0 | 31.2 K to 0 (-100.00 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Sell | U | 125.00 | 9,153 | 1,144,125 | 31,150 | 40.3 K to 31.2 K (-22.71 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Foster-Cheek Kaye I | SVP, Global Human R ... | Option Exercise | D | 88.86 | 15,100 | 1,341,786 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Foster-Cheek Kaye I | SVP, Global Human R ... | Option Exercise | D | 37.68 | 22,059 | 831,183 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Foster-Cheek Kaye I | SVP, Global Human R ... | Option Exercise | D | 37.68 | 3,407 | 128,376 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Foster-Cheek Kaye I | SVP, Global Human R ... | Option Exercise | D | 35.18 | 9,917 | 348,880 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Foster-Cheek Kaye I | SVP, Global Human R ... | Option Exercise | D | 35.18 | 1,750 | 61,565 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Foster-Cheek Kaye I | SVP, Global Human R ... | Option Exercise | D | 26.38 | 21,172 | 558,517 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Foster-Cheek Kaye I | SVP, Global Human R ... | Option Exercise | D | 26.38 | 11,660 | 307,591 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Foster-Cheek Kaye I | SVP, Global Human R ... | Sell | D | 125.00 | 21,400 | 2,675,000 | 0 | 21.4 K to 0 (-100.00 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Foster-Cheek Kaye I | SVP, Global Human R ... | Sell | U | 125.00 | 5,666 | 708,250 | 21,400 | 27.1 K to 21.4 K (-20.93 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | COLES N ANTHONY | Chairman & CEO | Option Exercise | D | 88.86 | 75,300 | 6,691,158 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | COLES N ANTHONY | Chairman & CEO | Option Exercise | D | 37.68 | 139,947 | 5,273,203 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | COLES N ANTHONY | Chairman & CEO | Option Exercise | D | 37.68 | 2,653 | 99,965 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | COLES N ANTHONY | Chairman & CEO | Option Exercise | D | 35.18 | 45,283 | 1,593,056 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | COLES N ANTHONY | Chairman & CEO | Option Exercise | D | 35.18 | 2,842 | 99,982 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | COLES N ANTHONY | Chairman & CEO | Option Exercise | D | 30.28 | 143,698 | 4,351,175 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | COLES N ANTHONY | Chairman & CEO | Option Exercise | D | 30.28 | 3,302 | 99,985 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | COLES N ANTHONY | Chairman & CEO | Option Exercise | D | 28.55 | 5,247 | 149,802 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | COLES N ANTHONY | Chairman & CEO | Sell | D | 125.00 | 105,566 | 13,195,750 | 0 | 105.6 K to 0 (-100.00 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | COLES N ANTHONY | Chairman & CEO | Sell | U | 125.00 | 25,632 | 3,204,000 | 105,566 | 131.2 K to 105.6 K (-19.54 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | RINGO WILLIAM R | Director | Option Exercise | D | 88.86 | 5,900 | 524,274 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | RINGO WILLIAM R | Director | Option Exercise | D | 76.79 | 2,000 | 153,580 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | RINGO WILLIAM R | Director | Option Exercise | D | 37.68 | 5,000 | 188,400 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | RINGO WILLIAM R | Director | Option Exercise | D | 36.61 | 5,417 | 198,316 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | RINGO WILLIAM R | Director | Sell | D | 125.00 | 2,100 | 262,500 | 0 | 2.1 K to 0 (-100.00 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | RINGO WILLIAM R | Director | Sell | U | 125.00 | 7,737 | 967,125 | 2,100 | 9.8 K to 2.1 K (-78.65 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | GRILLO LOPEZ ANTONIO J | Director | Option Exercise | D | 88.86 | 5,900 | 524,274 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | GRILLO LOPEZ ANTONIO J | Director | Sell | D | 125.00 | 2,100 | 262,500 | 0 | 2.1 K to 0 (-100.00 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | LUNDBERG MAGNUS | Director | Option Exercise | D | 88.86 | 5,900 | 524,274 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | LUNDBERG MAGNUS | Director | Option Exercise | D | 76.79 | 2,000 | 153,580 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | LUNDBERG MAGNUS | Director | Option Exercise | D | 37.68 | 5,000 | 188,400 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | LUNDBERG MAGNUS | Director | Option Exercise | D | 35.18 | 5,000 | 175,900 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | LUNDBERG MAGNUS | Director | Option Exercise | D | 30.28 | 5,000 | 151,400 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | LUNDBERG MAGNUS | Director | Option Exercise | D | 28.55 | 4,041 | 115,371 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | LUNDBERG MAGNUS | Director | Option Exercise | D | 33.70 | 10,000 | 337,000 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | LUNDBERG MAGNUS | Director | Option Exercise | D | 31.70 | 10,000 | 317,000 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | LUNDBERG MAGNUS | Director | Sell | D | 125.00 | 2,100 | 262,500 | 0 | 2.1 K to 0 (-100.00 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | LUNDBERG MAGNUS | Director | Sell | U | 125.00 | 12,116 | 1,514,500 | 2,100 | 14.2 K to 2.1 K (-85.23 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Option Exercise | D | 88.86 | 24,300 | 2,159,298 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Option Exercise | D | 37.68 | 12,156 | 458,038 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Option Exercise | D | 37.68 | 1,144 | 43,106 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Option Exercise | D | 33.70 | 44,132 | 1,487,248 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Option Exercise | D | 33.70 | 11,868 | 399,952 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Sell | D | 125.00 | 28,575 | 3,571,875 | 0 | 28.6 K to 0 (-100.00 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Sell | U | 125.00 | 7,336 | 917,000 | 28,575 | 35.9 K to 28.6 K (-20.43 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Nevinny Corinne H | Director | Option Exercise | D | 88.86 | 5,900 | 524,274 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Nevinny Corinne H | Director | Option Exercise | D | 76.79 | 2,000 | 153,580 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Nevinny Corinne H | Director | Option Exercise | D | 37.68 | 5,000 | 188,400 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Nevinny Corinne H | Director | Option Exercise | D | 35.18 | 5,000 | 175,900 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Nevinny Corinne H | Director | Option Exercise | D | 30.28 | 5,000 | 151,400 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Nevinny Corinne H | Director | Option Exercise | D | 28.55 | 2,410 | 68,806 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Nevinny Corinne H | Director | Option Exercise | D | 31.04 | 10,000 | 310,400 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Nevinny Corinne H | Director | Option Exercise | D | 44.12 | 10,000 | 441,200 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Nevinny Corinne H | Director | Option Exercise | D | 24.14 | 20,000 | 482,800 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Nevinny Corinne H | Director | Sell | D | 125.00 | 2,100 | 262,500 | 0 | 2.1 K to 0 (-100.00 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WIGGANS THOMAS G | Director | Option Exercise | D | 88.86 | 5,900 | 524,274 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WIGGANS THOMAS G | Director | Option Exercise | D | 76.79 | 2,000 | 153,580 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WIGGANS THOMAS G | Director | Option Exercise | D | 37.68 | 5,000 | 188,400 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WIGGANS THOMAS G | Director | Option Exercise | D | 35.18 | 5,000 | 175,900 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WIGGANS THOMAS G | Director | Option Exercise | D | 30.28 | 5,000 | 151,400 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WIGGANS THOMAS G | Director | Option Exercise | D | 28.55 | 5,287 | 150,944 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WIGGANS THOMAS G | Director | Option Exercise | D | 25.05 | 10,000 | 250,500 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WIGGANS THOMAS G | Director | Option Exercise | D | 25.67 | 10,000 | 256,700 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WIGGANS THOMAS G | Director | Option Exercise | D | 27.63 | 6,000 | 165,780 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WIGGANS THOMAS G | Director | Sell | D | 125.00 | 2,100 | 262,500 | 0 | 2.1 K to 0 (-100.00 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | WIGGANS THOMAS G | Director | Sell | U | 125.00 | 6,015 | 751,875 | 2,100 | 8.1 K to 2.1 K (-74.12 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corp. Dev & St ... | Option Exercise | D | 88.86 | 20,100 | 1,786,086 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corp. Dev & St ... | Option Exercise | D | 37.68 | 43,247 | 1,629,547 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corp. Dev & St ... | Option Exercise | D | 37.68 | 2,653 | 99,965 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corp. Dev & St ... | Option Exercise | D | 35.18 | 37,575 | 1,321,889 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corp. Dev & St ... | Option Exercise | D | 35.18 | 925 | 32,542 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corp. Dev & St ... | Option Exercise | D | 35.18 | 37,500 | 1,319,250 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corp. Dev & St ... | Option Exercise | D | 35.18 | 2,500 | 87,950 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corp. Dev & St ... | Option Exercise | D | 30.28 | 38,548 | 1,167,233 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corp. Dev & St ... | Option Exercise | D | 30.28 | 3,452 | 104,527 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corp. Dev & St ... | Option Exercise | D | 28.55 | 2,625 | 74,944 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corp. Dev & St ... | Option Exercise | D | 35.67 | 72,788 | 2,596,348 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corp. Dev & St ... | Option Exercise | D | 35.67 | 11,212 | 399,932 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corp. Dev & St ... | Sell | D | 125.00 | 30,250 | 3,781,250 | 0 | 30.3 K to 0 (-100.00 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corp. Dev & St ... | Sell | U | 125.00 | 1,833 | 229,125 | 30,250 | 32.1 K to 30.3 K (-5.71 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Option Exercise | D | 88.86 | 5,900 | 524,274 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Option Exercise | D | 76.79 | 2,000 | 153,580 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Option Exercise | D | 37.68 | 5,000 | 188,400 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Option Exercise | D | 35.18 | 5,000 | 175,900 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Option Exercise | D | 30.28 | 5,000 | 151,400 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Option Exercise | D | 28.55 | 5,726 | 163,477 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Option Exercise | D | 45.09 | 10,000 | 450,900 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Option Exercise | D | 26.69 | 10,000 | 266,900 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Option Exercise | D | 28.41 | 1,000 | 28,410 | 0 | |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Sell | D | 125.00 | 2,100 | 262,500 | 0 | 2.1 K to 0 (-100.00 %) |
Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Sell | U | 125.00 | 12,790 | 1,598,750 | 2,100 | 14.9 K to 2.1 K (-85.90 %) |
Sep 05 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Payment of Exercise | F | 123.62 | 2,099 | 259,478 | 35,911 | 38 K to 35.9 K (-5.52 %) |
Aug 14 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Option Exercise | M | 37.68 | 1,250 | 47,100 | 13,300 | |
Aug 14 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Option Exercise | M | 33.70 | 7,000 | 235,900 | 56,000 | |
Aug 14 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Sell | S | 126.93 | 1,061 | 134,667 | 46,585 | 47.6 K to 46.6 K (-2.23 %) |
Aug 14 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Sell | S | 126.89 | 8,250 | 1,046,810 | 47,646 | 55.9 K to 47.6 K (-14.76 %) |
Aug 14 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Buy | M | 37.68 | 1,250 | 47,100 | 55,896 | 54.6 K to 55.9 K (+2.29 %) |
Aug 14 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Buy | M | 33.70 | 7,000 | 235,900 | 54,646 | 47.6 K to 54.6 K (+14.69 %) |
Aug 12 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Sell | S | 128.21 | 2,492 | 319,499 | 40,303 | 42.8 K to 40.3 K (-5.82 %) |
Aug 08 2013 | ONXX | ONYX PHARMACEUTICA ... | Foster-Cheek Kaye I | SVP, Global Human R ... | Option Exercise | M | 37.68 | 2,388 | 89,980 | 25,466 | |
Aug 08 2013 | ONXX | ONYX PHARMACEUTICA ... | Foster-Cheek Kaye I | SVP, Global Human R ... | Option Exercise | M | 35.18 | 1,750 | 61,565 | 11,667 | |
Aug 08 2013 | ONXX | ONYX PHARMACEUTICA ... | Foster-Cheek Kaye I | SVP, Global Human R ... | Option Exercise | M | 26.38 | 4,740 | 125,041 | 32,832 | |
Aug 08 2013 | ONXX | ONYX PHARMACEUTICA ... | Foster-Cheek Kaye I | SVP, Global Human R ... | Sell | S | 133.68 | 500 | 66,840 | 27,066 | 27.6 K to 27.1 K (-1.81 %) |